Componenta (CTH1V) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
5 Jun, 2025Executive summary
Net sales for Q1 2025 reached EUR 28.8 million, up 22.4% year-over-year.
EBITDA improved to EUR 2.4 million from EUR -0.2 million in Q1 2024.
Operating profit was EUR 1.1 million, compared to a loss of EUR -1.5 million in the prior year; net result was EUR 0.5 million.
Order book at period end stood at EUR 17.4 million, up from EUR 15.8 million, supported by new business acquisitions.
Profitability gains driven by productivity, quality improvements, and pricing adjustments, despite modest production volumes and labor disruptions.
Financial highlights
Net sales increased sequentially each quarter, reaching EUR 28.8 million in Q1 2025.
Net result: EUR 0.5 million (vs. EUR -2.1 million); EPS: EUR 0.05 (vs. EUR -0.21).
Cash and cash equivalents at end of March were EUR 6.3 million, up from EUR 4.3 million.
Unused revolving credit facilities totaled EUR 4.0 million, with an additional USD 3 million convertible bond available from July 2025.
Cash flow from operating activities was negative at EUR -1.1 million, down from EUR -0.8 million, mainly due to working capital changes.
Outlook and guidance
Net sales and adjusted EBITDA for 2025 are expected to improve over 2024, which saw EUR 97.1 million in net sales and EUR 4.9 million in adjusted EBITDA.
Industry outlook cautiously optimistic; order book growth and signs of recovery in agricultural machinery expected by end-2025.
Focus areas for 2025 include growth, profitability, new sales, and ramp-up of new production.
Latest events from Componenta
- Net sales and profitability surged, with strong cash and order book growth supporting a positive outlook.CTH1V
Q4 20256 Mar 2026 - Sales and EBITDA surged, order book grew, and liquidity stayed stable amid uncertainty.CTH1V
Q3 202530 Oct 2025 - Sales and profit surged, led by energy and defence, with strong cash flow and positive outlook.CTH1V
Q2 202523 Jul 2025 - Net sales and EBITDA fell, but Q3 improved and acquisitions support future growth.CTH1V
Q3 202413 Jun 2025 - Sales and profit fell, but new contracts and acquisitions signal recovery in H2 2024.CTH1V
Q2 202413 Jun 2025 - EBITDA and cash flow surged despite lower net sales, with a strong order book and positive outlook.CTH1V
Q4 20245 Jun 2025